Enzo A. Culiolo

A Creative/Art director, Web Developer/Designer, UI/UX Designer, a speaker-in-training, and a husband to the most wonderful/beautiful woman that knows the law

[Ametris (formerly ActiGraph) @actigraph]

Thank you to @QT9Software for sponsoring this #ADDS2022 networking break!

[Ametris (formerly ActiGraph) @actigraph]

Thank you to our #ADDS2022 Platinum sponsor @Parexel for sponsoring last night’s Customer Appreciation Dinner, which featured a show from New York, NY Dueling Pianos!

[Ametris (formerly ActiGraph) @actigraph]

Incredible #ADDS2022 panel discussion about unleashing the potential of digital health technologies! #DHTs

Featuring:
Peter Fernandes, Bellerophon
Carrie Northcott, @pfizer
Tina Duong, @StanfordMed
Rohit Aggarwal, @docrota @pitttweet
Christine Guo, @ChristineGuo_AG #ActiGraph

[Ametris (formerly ActiGraph) @actigraph]

#ADDS2022 Has officially begun! 🎉 Our CEO, Jeremy Wyatt, is giving his opening remarks for this full day of conference sessions. We’re honored to have attendees joining us from all over the world for this exciting event!

[Ametris (formerly ActiGraph) @actigraph]

#ADDS2022
@JohnsHopkinsSPH’s @jenschrack is presenting novel applications of wearable device data to enhance physical activity research in older adults.

[Ametris (formerly ActiGraph) @actigraph]

Our first #ADDS2022 keynote speaker today is @eperakslis from @DCRINews! He’s sharing insight on why the future of #clinicaltrials is hybrid.

[Ametris (formerly ActiGraph) @actigraph]

Kong Chen from @NIH is speaking at #ADDS2022 on how to translate movement data to metabolic rate.

[Ametris (formerly ActiGraph) @actigraph]

Thank you @GoHumanFirst for sponsoring this morning’s #ADDS2022 networking break!

[Ametris (formerly ActiGraph) @actigraph]

Rob Motl from @UICAHS is sharing applications of #accelerometry in #MultipleSclerosis.
#ADDS2022 #MSresearch

[Enzo A. Culiolo @eculiolo09]

@Airbnb help me understand the new policies for maintaining super host status. Your new algorithms and thresholds don’t account for the human factor. As long time super hosts, we need to be treated differently and have some exceptions to the new policies.

[Ametris (formerly ActiGraph) @actigraph]

#ActiGraph is honored to welcome Dr. Patty Freedson from @UMassAmherst as a Keynote Speaker at #ADDS2021. She pioneered the use of #wearables to measure activity and sedentary behavior, and many of the algorithms she helped develop are still used today! https://t.co/ZbYDqdDr21

[Ametris (formerly ActiGraph) @actigraph]

A recent study examined the association between #accelerometer output & energy expenditure across different walking speeds in participants with #parkinsonsdisease, and further generated cut-points that represent a metric for quantifying time spent in MVPA. https://t.co/sUiZkWkEMa

[Ametris (formerly ActiGraph) @actigraph]

Please join us today for the #INTIENTSummit where ActiGraph's Head of Business Operations, Matt Biggs, will be hosting a virtual meeting room! This event brings together industry leaders & peers to collaborate & resolve the challenges facing Life Sciences. https://t.co/a3qVbpcLLD

[Ametris (formerly ActiGraph) @actigraph]

ActiGraph is looking for a Business Development Manager! Our mission is to help people live longer, better lives, and we understand the importance of cultivating relationships with our partners in the pharma research community. Check out our careers page: https://t.co/jnnhNkqw0o

[Ametris (formerly ActiGraph) @actigraph]

Please join us tomorrow! Jeremy Wyatt, ActiGraph CEO, & experts from
@ElektraLabs, @AtlanticCouncil, & @SamsungHealthUS will join the discussion and Q&A session, "What Level of Evidence is Needed to Evaluate Biomarkers and Measurements?” https://t.co/TRyk3gujy2

[Ametris (formerly ActiGraph) @actigraph]

A recent study aimed to determine the bidirectional associations between emergency nurses’ occupational & leisure time activity levels on workdays. Physical activity (PA) prior to a morning shift was associated with more sedentary time and less PA at work. https://t.co/KI5OaC3GHS

[Ametris (formerly ActiGraph) @actigraph]

Join us next week for #INTIENTSummit! This event brings together industry leaders & peers to collaborate & resolve the challenges facing Life Sciences. ActiGraph's Head of Business Operations, Matt Biggs, will host a virtual meeting room. Register today: https://t.co/crjy7oE6mh

[Ametris (formerly ActiGraph) @actigraph]

On Nov 17th, #ActiGraph CEO, Jeremy Wyatt, along with panelists from @ElektraLabs, @AtlanticCouncil, & @SamsungHealthUS will join the discussion and Q&A session, "What Level of Evidence is Needed to Evaluate Biomarkers and Measurements?” Register today: https://t.co/2T6yooGQl1

[Ametris (formerly ActiGraph) @actigraph]

On Nov 17th, #ActiGraph CEO, Jeremy Wyatt, along with panelists from @ElektraLabs, @AtlanticCouncil, & @SamsungHealthUS will join the discussion and Q&A session, "What Level of Evidence is Needed to Evaluate Biomarkers and Measurements?” Register today: https://t.co/yKDR4XmOSh

[Ametris (formerly ActiGraph) @actigraph]

Please join us virtually this Friday for our Spotlight Session at @CNSSummit! Moderated by #ActiGraph CEO, Jeremy Wyatt, and featuring a panel of experts from @bmsnews,
@TakedaPharma, @Roche, and @UCSanDiego. Register today: https://t.co/X6pHow4lbw #CNSSummit #wearables #V3